Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Award-Winning Documentary on Rett Syndrome Holds D.C. Premiere July 9th
  • USA - English


News provided by

Rett Syndrome Research Trust

Jul 02, 2013, 03:00 ET

Share this article

Share toX

Share this article

Share toX

RETT Documentary Poster
RETT Documentary Poster

“The long-standing assumption that severe childhood neurological disorders are beyond repair is collapsing, and Rett Syndrome research is a major driver of this new perspective."

Post this

Washington, D.C. (PRWEB) July 02, 2013 -- Rett Syndrome, a woman’s disease most women have never heard of, will be the focus of a documentary film screening and panel discussion. The award-winning film RETT: THERE IS HOPE, which showcases the struggles of families living with Rett Syndrome, an autism spectrum disorder that strikes toddler girls, will hold its Washington, D.C. premiere July 9th at 5:30 p.m. at the National Academies’ Keck Center, 500 Fifth St. N.W. Members of the public are invited to attend the free screening, reception and panel discussion held with support from the Institute of Medicine (IOM), an independent, nonprofit organization that provides unbiased and authoritative advice to decision makers and the public about the nation’s most pressing health and health care questions.

RETT tells the story of three families living with the syndrome and captures the spectrum of emotions ranging from the ever-present stress to the love, devotion, and determination displayed by the affected children, their families, and the scientists working on a cure. Onset of Rett Syndrome is heralded by loss of speech and motor control, including functional hand use. Many children suffer from seizures, anxiety, and severe autonomic, orthopedic, breathing and digestive problems. Most live into adulthood and require total, round-the-clock care.

The panel discussion following the screening will address the impact of rare disease research on the broader community as well as NIH and industry translational efforts. “The long-standing assumption that severe childhood neurological disorders are beyond repair is collapsing, and Rett Syndrome research is a major driver of this new perspective. Families all around the globe who love a child with Rett Syndrome are encouraged and inspired by the current state of research. Our girls are waiting for a cure – time is of the essence,” said Coenraads. Panel discussants will feature:

• President of the Institute of Medicine, Dr. Harvey V. Fineberg
• Institute of Medicine member and RSRT Advisor, Dr. Huda Zoghbi, who identified the genetic cause of Rett Syndrome in 1999 after a 16-year search
• RSRT Executive Director and parent of a teenage daughter with Rett, Monica Coenraads
• President of REM Entertainment, filmmaker Jason Rem

“It is quite fitting that this film centers on the girls and their families as the scientific community continues to learn tremendously from the patients. Rett Syndrome has played an immense role in my research since the mid 1980’s. It’s been gratifying to witness and be a part of the growing research momentum. I am optimistic that we will be able to dramatically improve the lives of girls and women who each day battle the effects of this debilitating disorder,” shares Zoghbi.

The documentary was made with an all-volunteer effort led by award-winning filmmaker Jason Rem. “Our goal here is to educate D.C. individuals as well as media who can effect change on this debilitating disease. Through the panel discussion, we hope to highlight the issues and brilliant science that is leading to breakthroughs. It is vital that the public at large learns about and appreciates the importance of Rett Syndrome and the science which could lead to a cure,” said Rem.

A reception for attendees will commence at 5:30 p.m.; the screening which starts at 6:30 p.m. will be followed by a panel discussion and Q & A at 7:30 p.m. To RSVP online please visit http://www.rsrt.org/screening. To RSVP by phone or email or for more information please connect with the press contacts below.

To purchase a DVD and watch the trailer please visit: http://www.rsrt.org/rett-and-mecp2-disorders/thereishope/.

About Rett Syndrome Research Trust
Press Contact: Monica Coenraads – 203.445.0041/monica(at)rsrt(dot)org
The Rett Syndrome Research Trust is a non-profit exclusively devoted to accelerating treatments and cures for Rett Syndrome and related MECP2 disorders. http://www.rsrt.org

About REM Entertainment
Press Contact: Jason Rem – 310.273.7818/jason(at)rementonline(dot)com
REM Entertainment has produced programming at the biggest sporting events in the world and content for the International Medical Corps, ESPN, FOX Sports, Sony, Nike and Red Bull. http://www.rementonline.com

Monica Coenraads, Rett Syndrome Research Trust, http://www.rsrt.org, (203) 445-0041, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.